Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes P Fiorina, M Jurewicz, A Augello, A Vergani, S Dada, S La Rosa, M Selig, ... The journal of Immunology 183 (2), 993-1004, 2009 | 473 | 2009 |
ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration S Zandi, S Nakao, KH Chun, P Fiorina, D Sun, R Arita, M Zhao, E Kim, ... Cell reports 10 (7), 1173-1186, 2015 | 181 | 2015 |
Targeting CD22 reprograms B-cells and reverses autoimmune diabetes P Fiorina, A Vergani, S Dada, M Jurewicz, M Wong, K Law, E Wu, Z Tian, ... Diabetes 57 (11), 3013-3024, 2008 | 160 | 2008 |
Role of podocyte B7-1 in diabetic nephropathy P Fiorina, A Vergani, R Bassi, MA Niewczas, MM Altintas, MG Pezzolesi, ... Journal of the American Society of Nephrology 25 (7), 1415-1429, 2014 | 145 | 2014 |
Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7 A Vergani, S Tezza, F D’Addio, C Fotino, K Liu, M Niewczas, R Bassi, ... Circulation 127 (4), 463-475, 2013 | 133 | 2013 |
Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site M Ben Nasr, A Vergani, J Avruch, L Liu, E Kefaloyianni, F D’Addio, ... Acta diabetologica 52, 917-927, 2015 | 116 | 2015 |
Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection A Vergani, C Fotino, F D’Addio, S Tezza, M Podetta, F Gatti, M Chin, ... Diabetes 62 (5), 1665-1675, 2013 | 112 | 2013 |
Interleukin-10+ Regulatory B Cells Arise Within Antigen-Experienced CD40+ B Cells to Maintain Tolerance to Islet Autoantigens S Kleffel, A Vergani, S Tezza, M Ben Nasr, MA Niewczas, S Wong, ... Diabetes 64 (1), 158-171, 2015 | 110 | 2015 |
Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy F D’Addio, S La Rosa, A Maestroni, P Jung, E Orsenigo, MB Nasr, ... Cell stem cell 17 (4), 486-498, 2015 | 98 | 2015 |
Early increase of retinal arterial and venous blood flow velocities at color Doppler imaging in brittle type 1 diabetes after islet transplant alone M Venturini, P Fiorina, P Maffi, C Losio, A Vergani, A Secchi, ... Transplantation 81 (9), 1274-1277, 2006 | 92 | 2006 |
Targeting the CXCR4–CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1 P Fiorina, M Jurewicz, A Vergani, A Petrelli, M Carvello, F D’Addio, ... The Journal of Immunology 186 (1), 121-131, 2011 | 89 | 2011 |
The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing P Fiorina, G Pietramaggiori, SS Scherer, M Jurewicz, JC Mathews, ... Cell transplantation 19 (11), 1369-1381, 2010 | 89 | 2010 |
Impact of pancreas transplantation on type 1 diabetes-related complications C Gremizzi, A Vergani, V Paloschi, A Secchi Current opinion in organ transplantation 15 (1), 119-123, 2010 | 87 | 2010 |
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice A Vergani, F D'Addio, M Jurewicz, A Petrelli, T Watanabe, K Liu, K Law, ... diabetes 59 (9), 2253-2264, 2010 | 85 | 2010 |
Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes F D’Addio, P Maffi, P Vezzulli, A Vergani, A Mello, R Bassi, R Nano, ... Diabetes Care 37 (1), 267-276, 2014 | 52 | 2014 |
Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival P Fiorina, M Jurewicz, K Tanaka, N Behazin, A Augello, A Vergani, ... Diabetes 56 (4), 912-920, 2007 | 48 | 2007 |
The purinergic system in allotransplantation A Vergani, S Tezza, C Fotino, G Visner, A Pileggi, A Chandraker, ... American Journal of Transplantation 14 (3), 507-514, 2014 | 44 | 2014 |
B7h (ICOS-L) maintains tolerance at the fetomaternal interface LV Riella, S Dada, L Chabtini, B Smith, L Huang, P Dakle, B Mfarrej, ... The American journal of pathology 182 (6), 2204-2213, 2013 | 42 | 2013 |
Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation P Fiorina, P Vezzulli, R Bassi, C Gremizzi, M Falautano, F D’Addio, ... Diabetes Care 35 (2), 367-374, 2012 | 42 | 2012 |
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response A Petrelli, M Carvello, A Vergani, KM Lee, S Tezza, M Du, S Kleffel, ... Diabetes 60 (12), 3223-3234, 2011 | 38 | 2011 |